BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6724109)

  • 1. Decarboxylation of uroporphyrinogen I and III in 2,3,7,8-tetrachlorodibenzo-p-dioxin induced porphyria in mice.
    Cantoni L; Dal Fiume D; Ruggieri R
    Int J Biochem; 1984; 16(5):561-5. PubMed ID: 6724109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.
    Smith AG; Francis JE
    Biochem J; 1981 Apr; 195(1):241-50. PubMed ID: 7306050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decarboxylation of uroporphyrinogen III by erythrocyte uroporphyrinogen decarboxylase. Evidence for a random decarboxylation mechanism.
    Luo J; Lim CK
    Biochem J; 1990 Jun; 268(2):513-5. PubMed ID: 2363688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
    Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
    Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some kinetic properties of human red cell uroporphyrinogen decarboxylase.
    de Verneuil H; Grandchamp B; Nordmann Y
    Biochim Biophys Acta; 1980 Jan; 611(1):174-86. PubMed ID: 7350915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different susceptibility of mouse tissues to porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Cantoni L; dal Fiume D; Ferraroli A; Salmona M; Ruggieri R
    Toxicol Lett; 1984 Feb; 20(2):201-10. PubMed ID: 6695411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme.
    de Catabbi SB; de Calmanovici RW; Minutolo C; Aldonatti C; San Martin de Viale LC
    Biochem Mol Biol Int; 1999 Jun; 47(6):945-56. PubMed ID: 10410240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrapyrroles as substrates and inhibitors of porphyrinogen carboxy - lyase from rat liver.
    San Martín de Viale LC; Aragonés A; Tomio JM
    Acta Physiol Lat Am; 1976; 26(5):403-14. PubMed ID: 1052603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from TCDD treated mice.
    Cantoni L; dal Fiume D; Rizzardini M; Ruggieri R
    Toxicol Lett; 1984 Feb; 20(2):211-7. PubMed ID: 6695412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
    Ríos de Molina MC; Wainstok de Calmanovici R; Grinstein M; San Martín de Viale LC
    Clin Chim Acta; 1980 Dec; 108(3):447-56. PubMed ID: 7471475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase.
    Smith AG; Francis JE
    Biochem J; 1979 Nov; 183(2):455-8. PubMed ID: 534506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random decarboxylation of uroporphyrinogen III by human hepatic uroporphyrinogen decarboxylase.
    Luo JL; Lim CK
    J Chromatogr; 1991 May; 566(2):409-13. PubMed ID: 1939452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction.
    Elder GH; Wyvill PC
    Enzyme; 1982; 28(2-3):186-95. PubMed ID: 7140720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
    Mukerji SK; Pimstone NR
    Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrinogenic effect of hexachlorobenzene and 2,3,7,8-tetrachlorodibenzo-para-dioxin: is an inhibitor involved in uroporphyrinogen decarboxylase inactivation?
    Cantoni L; Graziani A; Rizzardini M; Saletti MC
    IARC Sci Publ; 1986; (77):449-56. PubMed ID: 3596737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the active centre(s) of rat liver porphyrinogen carboxy-lyase. In vivo effect of hexachlorobenzene on decarboxylation site(s) of porphyrinogens.
    Billi de Catabbi SC; San Martin de Viale LC
    Int J Biochem; 1994 Apr; 26(4):595-600. PubMed ID: 8013745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of mouse liver uroporphyrinogen decarboxylase by reverse-phase high-performance liquid chromatography.
    Francis JE; Smith AG
    Anal Biochem; 1984 May; 138(2):404-10. PubMed ID: 6742418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P-450-mediated uroporphyrinogen oxidation.
    Lambrecht RW; Jacobs JM; Sinclair PR; Sinclair JF
    Biochem J; 1990 Jul; 269(2):437-41. PubMed ID: 2117439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
    Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
    J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.